Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-25-000220
Filing Date
2025-05-12
Accepted
2025-05-12 10:44:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 9448
2 JOINT FILING AGREEMENT Rule13D_JointFilingAgreement.htm EX-99 3737
  Complete submission text file 0000902219-25-000220.txt   15202
Mailing Address 125 SUMMER STREET BOSTON MA 02110
Business Address 125 SUMMER STREET BOSTON MA 02110 7818487100
HAEMONETICS CORP (Subject) CIK: 0000313143 (see all company filings)

EIN.: 042882273 | State of Incorp.: MA | Fiscal Year End: 0329
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-48277 | Film No.: 25933407
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210
Business Address C/O WELLINGTON MANAGEMENT COMPANY LLP 280 CONGRESS STREET BOSTON MA 02210 6179515000
WELLINGTON MANAGEMENT GROUP LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 0000